Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-07-31

Clinical Trial Update: Accuracy of Markerless Motion Capture Evaluation in Parkinson's Disease After DBS [NA]

View source ↗

Summary

The study completed an evaluation of markerless motion capture for assessing movement in Parkinson disease patients after deep brain stimulation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Hospital Zambrano Hellion | Conditions: Parkinson Disease | NA | Status: COMPLETED